Molecular characterization of clinical responses to PD ‐1/PD‐L1 inhibitors in non‐small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD‐1 inhibitors in Chinese patients

This study is registered in th e Chinese Clinical Trial Registry (ChiCTR1900021395).

Source: Thoracic Cancer - April 22, 2019 Category: Cancer & Oncology Authors: Peng Song, Xiaoxia Cui, Li Bai, Xiangdong Zhou, Xiaoli Zhu, Jian Zhang, Faguang Jin, Jianping Zhao, Chengzhi Zhou, Yanbin Zhou, Xiaoju Zhang, Kai Wang, Qi Wang, Yao Yu, Xiaoyu Zhang, Chunxue Bai, Li Zhang Tags: STUDY PROTOCOL Source Type: research